{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:55:14Z","timestamp":1792814114798,"version":"4.5.0"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T00:00:00Z","timestamp":1505779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Victorian Cytology Service (VCS) Ltd"},{"name":"Roche Molecular Systems"},{"name":"Roche Tissue Diagnostics, AZ USA"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1002388","type":"journal-article","created":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T13:25:14Z","timestamp":1505827514000},"page":"e1002388","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":85,"title":["Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial"],"prefix":"10.1371","volume":"14","author":[{"given":"Karen","family":"Canfell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5439-6552","authenticated-orcid":true,"given":"Michael","family":"Caruana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val","family":"Gebski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8003-956X","authenticated-orcid":true,"given":"Jessica","family":"Darlington-Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Heley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Brotherton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Gertig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe J.","family":"Jennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle","family":"Farnsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0226-8647","authenticated-orcid":true,"given":"Jeffrey","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2624-9061","authenticated-orcid":true,"given":"C. David","family":"Wrede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip E.","family":"Castle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Saville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,9,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomized controlled trials","volume":"383","author":"G Ronco","year":"2014","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"G Ronco","year":"2010","journal-title":"Lancet Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","article-title":"Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial","volume":"13","author":"DC Rijkaart","year":"2012","journal-title":"Lancet Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ejca.2011.01.008","article-title":"A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial","volume":"47","author":"HC Kitchener","year":"2011","journal-title":"Eur J Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"g130","DOI":"10.1136\/bmj.g130","article-title":"Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial","volume":"348","author":"KM Elfstr\u00f6m","year":"2014","journal-title":"BMJ"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1002\/ijc.30385","article-title":"Human papillomavirus testing versus cytology in primary cervical cancer screening: End-of-study and extended follow-up results from the Canadian cervical cancer screening trial","volume":"139","author":"SD Isidean","year":"2016","journal-title":"Int J Cancer"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ijc.30454","article-title":"HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer","volume":"140","author":"GS Ogilvie","year":"2017","journal-title":"Int J Cancer"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"TC Wright","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"8","key":"ref9","doi-asserted-by":"crossref","first-page":"dju153","DOI":"10.1093\/jnci\/dju153","article-title":"Reassurance Against Future Risk of Precancer and Cancer Conferred by a Negative Human Papillomavirus Test","volume":"106","author":"JC Gage","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"614","DOI":"10.5694\/mja13.10272","article-title":"Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach","volume":"199","author":"JML Brotherton","year":"2013","journal-title":"Med J Aust"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.vaccine.2013.11.075","article-title":"Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: Independent estimates from a nationally representative mobile phone survey","volume":"32","author":"J Brotherton","year":"2014","journal-title":"Vaccine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/infdis\/jis590","article-title":"Fall in human papillomavirus prevalence following a national vaccination program","volume":"206","author":"SN Tabrizi","year":"2012","journal-title":"J Infect Dis"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/infdis\/jiu370","article-title":"Fall in genital warts diagnoses in the general and indigenous Australian population following implementation of a national human papillomavirus vaccination program: analysis of routinely collected national hospital data","volume":"211","author":"M Smith","year":"2015","journal-title":"J Infect Dis"},{"key":"ref14","unstructured":"Australian Institute of Health and Welfare. Cervical screening in Australia 2011\u20132012. Canberra: Australian Institute of Health and Welfare; 2014 [cited 2017 Aug 15]. Cancer series no. 82. Cat. no. CAN 79. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.aihw.gov.au\/WorkArea\/DownloadAsset.aspx?id=60129547030\" xlink:type=\"simple\">http:\/\/www.aihw.gov.au\/WorkArea\/DownloadAsset.aspx?id=60129547030<\/ext-link>."},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.5694\/mja15.01038","article-title":"HPV vaccine impact in Australian women: ready for an HPV-based screening program","volume":"204","author":"J Brotherton","year":"2016","journal-title":"Med J Aust"},{"key":"ref16","year":"2005"},{"key":"ref17","unstructured":"Medical Services Advisory Committee. National Cervical Screening Program renewal: evidence review. Canberra: Commonwealth of Australia; 2013 [cited 2017 Aug 15]. MSAC application no. 1276. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.cancerscreening.gov.au\/internet\/screening\/publishing.nsf\/Content\/E6A211A6FFC29E2CCA257CED007FB678\/$File\/Review%20of%20Evidence%20notated%2013.06.14.pdf\" xlink:type=\"simple\">http:\/\/www.cancerscreening.gov.au\/internet\/screening\/publishing.nsf\/Content\/E6A211A6FFC29E2CCA257CED007FB678\/$File\/Review%20of%20Evidence%20notated%2013.06.14.pdf<\/ext-link>."},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1016\/S2468-2667(17)30007-5","article-title":"Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program","volume":"2","author":"JB Lew","year":"2017","journal-title":"Lancet Public Health"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ygyno.2016.10.031","article-title":"Triaging HPV-positive women with p16\/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial","volume":"144","author":"TC Wright Jr","year":"2017","journal-title":"Gynecol Oncol"},{"key":"ref20","unstructured":"Victorian Cervical Cytology Registry. Statistical report 2013. Carlton: Victorian Cervical Cytology Registry; 2013 [cited 2017 Aug 15]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.vccr.org\/site\/VCCR\/filesystem\/documents\/dataandresearch\/StatisticalReports\/VCS_StatisticsReport_2013_Web_SinglePages_Final.pdf\" xlink:type=\"simple\">http:\/\/www.vccr.org\/site\/VCCR\/filesystem\/documents\/dataandresearch\/StatisticalReports\/VCS_StatisticsReport_2013_Web_SinglePages_Final.pdf<\/ext-link>."},{"key":"ref21","unstructured":"Australian Institute of Health and Welfare. Cervical screening in Australia 2012\u20132013. Canberra: Australian Institute of Health and Welfare; 2015 [cited 2017 Aug 15]. Cancer series no. 93. Cat. no. CAN 91. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.aihw.gov.au\/WorkArea\/DownloadAsset.aspx?id=60129550872\" xlink:type=\"simple\">http:\/\/www.aihw.gov.au\/WorkArea\/DownloadAsset.aspx?id=60129550872<\/ext-link>."},{"issue":"Suppl 5","key":"ref22","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"M Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"ref23","first-page":"17","article-title":"The Australian example: an integrated approach to HPV vaccination and cervical screening","volume":"34","author":"K Canfell","year":"2015","journal-title":"HPV Today"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"46e1","DOI":"10.1016\/j.ajog.2011.07.024","article-title":"The ATHENA human papillomavirus study: design, methods, and baseline results","volume":"206","author":"TC Wright Jr","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"ref25","year":"2017"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1741-7015-9-104","article-title":"Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program","volume":"9","author":"SM Garland","year":"2011","journal-title":"BMC Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12913-016-1375-9","article-title":"Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use","volume":"16","author":"MA Smith","year":"2016","journal-title":"BMC Health Serv Res"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1002388","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T18:23:27Z","timestamp":1540232607000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1002388"}},"subtitle":[],"editor":[{"given":"Silvia","family":"de Sanjos\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,9,19]]},"references-count":27,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,9,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1002388","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,19]]}}}